These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 6253785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.
    Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE.
    N Engl J Med; 1982 May 13; 306(19):1136-40. PubMed ID: 6280047
    [Abstract] [Full Text] [Related]

  • 3. The multiple causes of hypercalcemia in malignant disease.
    Sherwood LM.
    N Engl J Med; 1980 Dec 11; 303(24):1412-3. PubMed ID: 6253787
    [No Abstract] [Full Text] [Related]

  • 4. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S, Adchi I, Yamaguchi K, Suzuki M, Shimada A, Sato Y, Nagaoka K, Abe K.
    Jpn J Cancer Res; 1985 Apr 11; 76(4):308-14. PubMed ID: 2989061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms of hypercalcemia in patients with head and neck cancer.
    Angel MF, Stewart A, Pensak ML, Pillsbury HR, Sasaki CT.
    Head Neck Surg; 1982 Apr 11; 5(2):125-9. PubMed ID: 7169331
    [Abstract] [Full Text] [Related]

  • 9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M, Minebois-Villégas A, Lortholary A, Legrand E, Pascaretti C, Giraud P, Subra JF, Boasson M, Jallet P.
    Rev Rhum Engl Ed; 1995 Mar 11; 62(3):189-96. PubMed ID: 7788336
    [Abstract] [Full Text] [Related]

  • 10. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF.
    N Engl J Med; 1990 Apr 19; 322(16):1106-12. PubMed ID: 2320080
    [Abstract] [Full Text] [Related]

  • 11. Immobilisation hypercalcemia.
    Evans RA, Bridgeman M, Hills E, Dunstan CR.
    Miner Electrolyte Metab; 1984 Apr 19; 10(4):244-8. PubMed ID: 6087102
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.
    Godsall JW, Burtis WJ, Insogna KL, Broadus AE, Stewart AF.
    Recent Prog Horm Res; 1986 Apr 19; 42():705-50. PubMed ID: 3016837
    [No Abstract] [Full Text] [Related]

  • 13. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia.
    Debacker M, Manderlier T, Nijs-Dewolf N, Six R, Corvilain J.
    Biomedicine; 1974 Aug 10; 21(8):338-41. PubMed ID: 4374265
    [No Abstract] [Full Text] [Related]

  • 14. Ectopic secretion of parathyroid hormone.
    Max MH, Lawrence PH.
    Surg Gynecol Obstet; 1980 Mar 10; 150(3):411-8. PubMed ID: 6986669
    [Abstract] [Full Text] [Related]

  • 15. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
    Shaw JW, Oldham SB, Rosoff L, Bethune JE, Fichman MP.
    J Clin Invest; 1977 Jan 10; 59(1):14-21. PubMed ID: 187621
    [Abstract] [Full Text] [Related]

  • 16. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
    Rubinger D, Friedlaender MM, Silver J, Wald H, Shumart T, Popovtzer MM.
    Miner Electrolyte Metab; 1988 Jan 10; 14(5):283-7. PubMed ID: 2845240
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE, Mahaffey JE, Bartter FC, Neer RM.
    J Clin Invest; 1977 Oct 10; 60(4):771-83. PubMed ID: 197123
    [Abstract] [Full Text] [Related]

  • 18. Differential diagnosis of hypercalcemia.
    Lafferty FW.
    J Bone Miner Res; 1991 Oct 10; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
    [Abstract] [Full Text] [Related]

  • 19. Nephrogenous cyclic adenosine monophosphate levels in normocalcemic cancer patients: its significance.
    Abramson EC, Kukreja SC, Lad TE, Shemerdiak WP, York PA.
    Horm Metab Res; 1984 Apr 10; 16(4):204-7. PubMed ID: 6327481
    [Abstract] [Full Text] [Related]

  • 20. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE, Deftos LJ, Bartter FC.
    J Clin Endocrinol Metab; 1978 Mar 10; 46(3):477-87. PubMed ID: 221521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.